Business

Business
Business

Wells Fargo stock slips on NII miss: can growth offset rate pressure?

Shares of Wells Fargo fell on Tuesday after the lender reported first-quarter net interest income that came in below Wall Street expectations, highlighting the near-term pressure from lower interest rates even as broader fundamentals remained stable. The stock dropped about 4.9% following the results, extending its year-to-date decline to roughly 13%. The reaction came despite

Read More
Business

What pushed COAI price to $0.56 and what next after pullback?

ChainOpera AI (COAI) has been one of those tokens that suddenly went from quiet to chaotic almost overnight. In just 24 hours, the token’s price exploded from the lower end of its range near $0.28 to a sharp peak around $0.565, before cooling off and settling closer to $0.3857. Moves like this rarely happen in

Read More
Business

Will Solana drop below $80 as downward pressure builds?

Bitcoin (BTC), Ethereum (ETH), and Ripple (XRP) are all trading in the red as the broader crypto market feels the pressure of the US-Iran conflict. Bitcoin’s price has slipped below $71,000, while Ether and XRP are trading below $2,200 and $1.35, respectively. Solana’s SOL is also underperforming and could face further selling pressure in the

Read More
Business

Why is Goldman Sachs stock falling despite blowout earnings?

Shares of Goldman Sachs fell more than 4% in premarket trading despite the Wall Street giant reporting a strong first-quarter performance, as investors focused on weaknesses in parts of its business and a more uncertain outlook. The bank said profit rose 19% in the first quarter, supported by a rebound in dealmaking and heightened market

Read More
Business

Palantir stock rebounds as Cathie Wood buys, Trump backs AI firm

Shares of Palantir Technologies rose in early trading on Monday, rebounding after a recent selloff as high-profile support from investors and political figures helped lift sentiment. The stock gained about 2.49% before the bell, trading near $131, even as broader market futures pointed lower amid geopolitical tensions. The move higher follows a difficult stretch for

Read More
Business

Dow Jones sinks 360 points as Iran talks collapse, oil surge rattles markets

US stocks fell sharply on Monday, starting the week on a weak note as investors reacted to the collapse of US-Iran weekend talks and a surge in oil prices following fresh military developments in the Strait of Hormuz. The Dow Jones Industrial Average dropped 368 points, while the S&P 500 fell around 0.32%, and the

Read More
Business

Why does HSBC expect the dollar to weaken despite gains?

The US dollar moved higher on Monday after weekend talks between Washington and Tehran failed to produce an agreement to end the ongoing conflict. According to CNBC, the greenback gained 0.3% against the euro, trading at $1.169, and rose 0.25% against the British pound to $1.342. The uptick in the currency came after peace negotiations

Read More
Business

US-Iran peace talks fail: what’s next for VanEck Semiconductor ETF (SMH)

The VanEck Semiconductor ETF (SMH) is in sharp focus on Apr. 13 after the high-stakes US-Iran peace talks collapsed, dashing hopes of a diplomatic resolution in the Middle East. SMH is now flashing technical caution as its relative strength index (RSI) hovers in the late 60s, a level that suggests the asset is rapidly approaching

Read More
Business

Intel stock is in a parabolic move, and a rare pattern points to a surge to $82

Intel stock price has staged a strong comeback this year and is now hovering near its all-time high. It soared to $62.40, up by over 245% from its lowest level last year, bringing its market capitalization to over $313 billion. Intel stock has soared as numerous catalysts converged INTC stock has rebounded in the past

Read More
Business

Revolution Medicines surges 38% on pancreatic cancer breakthrough

Shares of Revolution Medicines surged sharply on Monday after the company reported positive results from a late-stage trial of its experimental pancreatic cancer drug, raising hopes for a potential breakthrough in one of the deadliest forms of the disease. The stock climbed 38% after the opening bell, extending gains to 69% since the start of

Read More